The multi-kinase inhibitor afatinib serves as a novel candidate for the treatment of human uveal melanoma

PURPOSE: Uveal melanoma (UM) is the most common intraocular malignancy in adults with a poor prognosis and a high recurrence rate. Currently there is no effective treatment for UM. Multi-kinase inhibitors targeting dysregulated pro-tumorigenic signalling pathways have revolutionised anti-cancer trea...

Descripción completa

Detalles Bibliográficos
Autores principales: Shu, Wenying, Zhu, Xue, Wang, Ke, Cherepanoff, Svetlana, Conway, R. Max, Madigan, Michele C., Zhu, Hong, Zhu, Ling, Murray, Michael, Zhou, Fanfan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9424141/
https://www.ncbi.nlm.nih.gov/pubmed/35781872
http://dx.doi.org/10.1007/s13402-022-00686-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9424141/
https://www.ncbi.nlm.nih.gov/pubmed/35781872
http://dx.doi.org/10.1007/s13402-022-00686-5

Ejemplares similares